SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

CSPC Pharmaceutical Reports Updated Phase III Overall Survival Results

CSPC Pharmaceutical reported updated Phase III overall survival results for anbenitamab in HER2-positive advanced gastric cancer.

Related stories